Myocardial perfusion imaging in cardiac sarcoidosis: A "sine qua non" for prognosis assessment?
- PMID: 31792915
- DOI: 10.1007/s12350-019-01964-w
Myocardial perfusion imaging in cardiac sarcoidosis: A "sine qua non" for prognosis assessment?
References
-
- Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1305-23. - DOI
-
- Ishida Y, Yoshinaga K, Miyagawa M, Moroi M, Kondoh C, Kiso K, et al. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Ann Nucl Med 2014;28:393-403. - DOI
-
- Writing Group, Document reading Group, EACVI Reviewers: This document was reviewed by members of the EACVI Scientific Documents Committee for 2014–2016 and 2016–2018. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. Eur Heart J Cardiovasc Imaging 2017;18:1073-89.
-
- Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004;45:1989-98. - PubMed
-
- Berman JS, Govender P, Ruberg FL, Mazzini M, Miller EJ. Scadding revisited: A proposed staging system for cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2014;31:2-5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical